Trademark Overview
On Monday, May 17, 2021, a trademark application was filed for ARAVALENT with the United States Patent and Trademark Office. The USPTO has given the ARAVALENT trademark a serial number of 90716789. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, April 18, 2022. This trademark is owned by Aravalent Therapeutics, Inc.. The ARAVALENT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer
Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and d...
